Quick Answer
IRADIMED CORP reported Research And Development Expense of $2.98 million for the year ending 2025.
- IRADIMED CORP showed an increase of +5.0% in Research And Development Expense from 2024 to 2025.
- This data is from IRADIMED CORP's annual report (Form 10-K), filed with the SEC on March 6, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $204.4 thousand | Q3 2013: $299.4 thousand | Q1 2014: $224.3 thousand | Q2 2014: $225.5 thousand | Q3 2014: $303.5 thousand | Q1 2015: $342.3 thousand | Q2 2015: $403.4 thousand | Q3 2015: $518.6 thousand | Q1 2016: $234.3 thousand | Q2 2016: $291.8 thousand | Q3 2016: $457.1 thousand | Q1 2017: $541.3 thousand | Q2 2017: $449.0 thousand | Q3 2017: $382.7 thousand | Q1 2018: $379.8 thousand | Q2 2018: $396.0 thousand | Q3 2018: $373.6 thousand | Q1 2019: $352.6 thousand | Q2 2019: $331.3 thousand | Q3 2019: $369.5 thousand | Q1 2020: $430.3 thousand | Q2 2020: $482.7 thousand | Q3 2020: $476.9 thousand | Q1 2021: $475.8 thousand | Q2 2021: $453.7 thousand | Q3 2021: $480.7 thousand | Q1 2022: $519.1 thousand | Q2 2022: $662.6 thousand | Q3 2022: $491.6 thousand | Q1 2023: $3.00 million | Q2 2023: $962.0 thousand | Q3 2023: $452.6 thousand | Q1 2024: $821.0 thousand | Q2 2024: $801.1 thousand | Q3 2024: $639.5 thousand | Q1 2025: $624.2 thousand | Q2 2025: $877.4 thousand | Q3 2025: $674.4 thousand.
- Over the full 13 years of available data (2013 to 2025), IRADIMED CORP's Research And Development Expense has grown by 194.6%.
- Historical annual values: Fiscal year 2025: $2.98 million | Fiscal year 2024: $2.83 million | Fiscal year 2023: $2.86 million | Fiscal year 2022: $2.28 million | Fiscal year 2021: $1.91 million | Fiscal year 2020: $1.90 million | Fiscal year 2019: $1.43 million | Fiscal year 2018: $1.52 million | Fiscal year 2017: $1.72 million | Fiscal year 2016: $1.35 million | Fiscal year 2015: $1.76 million | Fiscal year 2014: $1.07 million | Fiscal year 2013: $1.01 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: